These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35822286)

  • 1. Tailored Approach for Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: A Pilot Study.
    Sousa FA; Machado AS; da Costa JC; Silva AC; Pinto AN; Coutinho MB; Meireles L; Sousa CAE
    Ann Otol Rhinol Laryngol; 2023 Jun; 132(6):657-666. PubMed ID: 35822286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection.
    Schmidt F; Azar C; Goektas O
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):48S-53S. PubMed ID: 36976171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell.
    Le Bon SD; Konopnicki D; Pisarski N; Prunier L; Lechien JR; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3113-3117. PubMed ID: 33423106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
    Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ
    Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
    Di Stadio A; Gallina S; Cocuzza S; De Luca P; Ingrassia A; Oliva S; Sireci F; Camaioni A; Ferreli F; Mercante G; Gaino F; Pace GM; La Mantia I; Brenner MJ
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4949-4961. PubMed ID: 37380908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study.
    Denis F; Septans AL; Periers L; Maillard JM; Legoff F; Gurden H; Moriniere S
    J Med Internet Res; 2021 May; 23(5):e29583. PubMed ID: 34003765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin": preliminary results.
    D'Ascanio L; Vitelli F; Cingolani C; Maranzano M; Brenner MJ; Di Stadio A
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4156-4162. PubMed ID: 34156697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review.
    Nag AK; Saltagi AK; Saltagi MZ; Wu AW; Higgins TS; Knisely A; Ting JY; Illing EA
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):806-817. PubMed ID: 35959948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
    Lechien JR; Le Bon SD; Saussez S
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive Olfactory Training in Post-COVID-19 Patients: A Multicenter Randomized Clinical Trial.
    Pires ÍAT; Steffens ST; Mocelin AG; Shibukawa DE; Leahy L; Saito FL; Amadeu NT; Lopes NMD; Garcia ECD; Albanese ML; De Mari LF; Ferreira IM; Veiga CA; Jebahi Y; Coifman H; Fornazieri MA; Hamerschmidt R
    Am J Rhinol Allergy; 2022 Nov; 36(6):780-787. PubMed ID: 35866202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.
    Lechien JR; Vaira LA; Saussez S
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1255-1263. PubMed ID: 36153785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of platelet-rich plasma on post-COVID chronic olfactory dysfunction.
    Evman MD; Cetin ZE
    Rev Assoc Med Bras (1992); 2023; 69(11):e20230666. PubMed ID: 37909619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell.
    Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
    Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory Training Impacts Olfactory Dysfunction Induced by COVID-19: A Pilot Study.
    Bérubé S; Demers C; Bussière N; Cloutier F; Pek V; Chen A; Bolduc-Bégin J; Frasnelli J
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):57-66. PubMed ID: 36529118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 32-Year-Old Man with Persistent Olfactory Dysfunction Following COVID-19 Whose Recovery Was Evaluated by Retronasal Olfactory Testing.
    Hirano K; Tanaka Y; Kamimura S; Suzaki I; Suzuki E; Kobayashi H
    Am J Case Rep; 2022 Sep; 23():e936496. PubMed ID: 36089753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial.
    Figueiredo LP; Paim PVDSL; Cerqueira-Silva T; Barreto CC; Lessa MM
    Braz J Otorhinolaryngol; 2024; 90(1):101356. PubMed ID: 37944311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.